Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Mild Neurocognitive Disorder clinical trials
1 of 3 indexed Mild Neurocognitive Disorder trials are currently recruiting.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Mild Neurocognitive Disorder: 3 US clinical trials tracked, 1 recruiting.
Mild Neurocognitive Disorder is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Palo Alto Veterans Institute for Research, running 1 of these trials.
Enrollment posture brief
Registry condition mild-neurocognitive-disorder
OPEN 1 | RECR 33% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Mild Neurocognitive Disorder lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Mild Neurocognitive Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Mild Neurocognitive Disorder is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Impact of Intensive Computerized Cognitive Training
Brigham and Women's Hospital
NCT06130735
Noninvasive Brain Stimulation for Mild Cognitive Impairment
Palo Alto Veterans Institute for Research
NCT03331796
C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors
Virginia Commonwealth University
NCT05984667
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Mild Neurocognitive Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Mild Neurocognitive Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Mild Neurocognitive Disorder page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Mild Neurocognitive Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Palo Alto Veterans Institute for Research sponsors the most Mild Neurocognitive Disorder trials on record, review their full trial history before evaluating a specific study. See Palo Alto Veterans Institute for Research's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mild Neurocognitive Disorder condition card totals 3 registered trials; most-linked intervention Placebo rTMS (Inactive); top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.